Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Catalysis. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN109136311B reveals cost-effective SAM production. Adenosine substrate replaces ATP. Reliable supplier for pharma intermediates.
Novel supported catalyst method improves yield and purity for folic acid production. Reduces reaction time and enhances supply chain reliability for global buyers.
Novel organofluorine-mediated synthesis of 2,3-unsaturated glycosides with high alpha-selectivity. Reduces heavy metal use and enables catalyst recycling for cost-effective API intermediate manufacturing.
Patent CN105801337B details a novel Pd-Cu catalytic route for phenanthrene compounds offering high purity and scalable manufacturing for global supply chains.
Patent CN113652407B reveals a novel carbonyl reductase mutant enabling strict S-selectivity and enhanced activity for cost-effective chiral diol manufacturing.
Patent CN101337950A details a continuous glycerol hydrochlorination process for epichlorohydrin. This report analyzes the cost-effective, eco-friendly catalytic route for reliable supply chain integration.
Patent CN109970568B reveals a room-temperature solid acid catalysis route for dimethyl 3-aminophthalate, offering significant cost reduction and supply chain stability for pharmaceutical manufacturing.
Novel Grignard route for bidentate phosphine ligands avoids n-butyllithium, offering safer, scalable manufacturing for hydroformylation catalysts.
Patent CN117947113A reveals dynamic kinetic resolution for high purity chiral intermediates. Enables cost reduction in pharmaceutical manufacturing with scalable enzyme catalysis.
Patent CN109897872B reveals enzymatic route for HIV intermediate. High conversion and purity ensure reliable pharmaceutical intermediates supplier capability for global procurement.
Patent CN113025544A reveals efficient whole-cell catalysis for L-phenyllactic acid. This method offers significant cost reduction and supply chain reliability for pharmaceutical intermediates manufacturing.
Patent CN109897872B details enzymatic reduction for HIV inhibitor intermediates. High purity and conversion enable cost reduction and reliable supply chain stability for global manufacturers.
Patent CN115819387A details a novel Ru-catalyzed route for S-Pro-Xylane, offering high purity and safety for cosmetic manufacturing supply chains.
Patent CN112812087A reveals a high-yield 3-step synthesis for Boseine. This method ensures superior purity and cost efficiency for cosmetic active ingredient manufacturing.
Patent CN118955276A details a novel oxidation-hydrolysis route for 2-bromo-5-hydroxybenzoic acid, offering significant cost reduction in pharmaceutical intermediates manufacturing and enhanced supply chain reliability.
Patent CN105130898A enables visible-light synthesis of gem-difluoro polycyclic compounds. Offers cost reduction and scalable manufacturing for pharmaceutical intermediates.
Patent CN119101667B reveals advanced enzyme fusion for ergothioneine. Discover cost reduction and supply chain reliability for nutritional ingredient manufacturing.
Patent CN102250052A details a continuous ionic liquid catalyzed process for high-purity cyclic carbonates, offering significant cost reduction and supply chain reliability for battery electrolyte manufacturing.
Novel lipase mutant enables high-purity pregabalin intermediate production with improved activity and supply chain reliability for pharmaceutical manufacturing.
Patent CN108707081B discloses a mild photocatalytic method for olefin difunctionalization, offering cost reduction in fine chemical manufacturing and reliable supply chain solutions.